654
Views
84
CrossRef citations to date
0
Altmetric
Research Article

Spray-freeze-dried dry powder inhalation of insulin-loaded liposomes for enhanced pulmonary delivery

, , &
Pages 639-648 | Received 19 Jan 2008, Accepted 14 May 2008, Published online: 03 Dec 2008

References

  • RU Agu, MI Ugwoke, M Armand, R Kinget, and N Verbeke. 2001. The lung as a route for systemic delivery of therapeutic proteins and peptides. Respir Res 2:198–209.
  • S Azarmi, X Tao, H Chen, Z Wang, WH Finlay, R Lobenberg, and WH Roa. 2006. Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles. Int J Pharm 319:155–161.
  • R Bi, and N Zhang. 2007. Liposomes as a carrier for pulmonary delivery of peptides and proteins. J Biomed Nanotech 3:332–341.
  • PA Bridges, and KM Taylor. 2000. An investigation of some of the factors influencing the jet nebulisation of liposomes. Int J Pharm 204:69–79.
  • A Çilek, N Çelebi, F Tırnaksız, and A Tay. 2005. A lecithin-based microemulsion of rh-insulin with aprotinin for oral administration: Investigation of hypoglycemic effects in non-diabetic and STZ-induced diabetic rats. Int J Pharm 298:176–185.
  • SA Cryan. 2005. Carrier-based strategies for targeting protein and peptide drugs to the lungs. AAPS J 7:E20–E41.
  • DA Edwards, J Hanes, G Caponetti, J Hrkach, A Ben-Jebria, ML Eskew, J Mintzes, D Deaver, N Lotan, and R Langer. 1997. Large porous particles for pulmonary drug delivery. Science 276:1868–1871.
  • JD Engstrom, DT Simpson, C Cloonan, ES Lai, RO WilliamsIII, G Barrie Kitto, and KP Johnston. 2007. Stable high surface area lactate dehydrogenase particles produced by spray freezing into liquid nitrogen. Eur J Pharm Biopharm 65:163–174.
  • M Gannslen. 1925. Uber inhalation von insulin. KlinWochenschr 4–71.
  • R Gupta, and PR Byron. 2000. Physical characterization of large porous particles for inhalation. Pharm Res 17:1437–1438.
  • R Jani, C Triplitt, C Reasner, and RA Defronzo. 2007. First approved inhaled insulin therapy for diabetes mellitus. Expert Opin Drug Deliv 4:63–76.
  • M Joshi, and A Misra. 2003. Disposition kinetics of ketotifen from liposomal dry powder for inhalation in rat lung. Clin Exp Pharmacol Physiol 30:153–156.
  • M Jurima-Romet, and PN Shek. 1991. Lung uptake of liposome-entrapped glutathione after intratracheal administration. J Pharm Pharmacol 43:6–10.
  • TR Kumar, K Soppimath, and SK Nachaegari. 2006. Novel delivery technologies for protein and peptide therapeutics. Curr Pharm Biotechnol 7:261–276.
  • KKM Leung, PA Bridges, and KMG Taylor. 1996. The stability of liposomes to ultrasonic nebulisation. Int J Pharm 145:95–102.
  • D Lu, and AJ Hickey. 2005. Liposomal dry powders as aerosols for pulmonary delivery of proteins. AAPS PharmSciTech 6:641–648.
  • YF Maa, PA Nguyen. 2001. Method of spray freeze drying proteins for pharmaceutical administration, US Patent 6284282.
  • YF Maa, PA Nguyen, T Sweeney, SJ Shire, and CC Hsu. 1999. Protein inhalation powders: Spray drying vs spray freeze drying. Pharm Res 16:249–254.
  • YF Maa, M Ameri, C Shu, LG Payne, and D Chen. 2004. Influenza vaccine powder formulation development: Spray-freeze-drying and stability evaluation. J Pharm Sci 93:1912–1923.
  • JP Mitchell, MW Nagel, KJ Wiersema, and CC Doyle. 2003. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: Comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 aerodynamic particle sizer aerosol spectrometer. AAPS PharmSciTech 4:E54.
  • R Mitra, I Pezron, Y Li, and AK Mitra. 2001. Enhanced pulmonary delivery of insulin by lung lavage fluid and phospholipids. Int J Pharm 217:25–31.
  • K Miyajima. 1997. Role of saccharides for the freeze-thawing and the freeze-drying of liposome. Adv Drug Deliv Rev 24:151–159.
  • R Niven, and H Schreier. 1990. Nebulization of liposomes. I. Effects of lipid composition. Pharm Res 7:1127–1133.
  • R Niven, M Speer, and H Schreier. 1991. Nebulization of liposomes. II. The effects of size and modeling of solute release profiles. Pharm Res 8:217–221.
  • R Niven, TM Carvajal, and H Schreier. 1992. Nebulization of liposomes. III. The effects of operating conditions and local environment. Pharm Res 9:515–520.
  • SH Park, JH Kwon, SH Lim, HW Park, and CW Kim. 2007. Characterization of human insulin microcrystals and their absorption enhancement by protease inhibitors in rat lungs. Int J Pharm 339:205–212.
  • J Patton, J Bukar, and S Nagarajan. 1999. Inhaled insulin. Adv Drug Deliv Rev 35:235–247.
  • JS Patton, JG Bukar, and MA Eldon. 2004. Clinical pharmacokinetics and pharmacodynamics of inhaled insulin. Clin Pharmacokinet 43:781–801.
  • H Pinto-Alphandary, A Andremont, and P Couvreur. 2000. Targeted delivery of antibiotics using liposomes and nanoparticles: Research and applications. Int J Antimicrob Agents 13:155–168.
  • G Pitcairn, S Reader, D Pavia, and S Newman. 2005. Deposition of corticosteroid aerosol in the human lung by Respimat Soft Mist inhaler compared to deposition by metered dose inhaler or by Turbuhaler dry powder inhaler. J Aerosol Med 18:264–272.
  • MA Radwan, and HY Aboul-Enein. 2002. The effect of oral absorption enhancers on the in vivo performance of insulin-loaded poly(ethylcyanoacrylate) nanospheres in diabetic rats. J Microencapsul 19:225–235.
  • G Scheuch, MJ Kohlhaeufl, and PBR Siekeier. 2006. Clinical perspectives on pulmonary systemic and macromolecular delivery. Adv Drug Deliv Rev 58:996–1008.
  • JC Scott-Moncrieff, ZZ Shao, and AK Mitra. 1994. Enhancement of intestinal insulin absorption by bile salt–fatty acid mixed micelles in dogs. J Pharm Sci 83:1465–1469.
  • SP Shah, and A Misra. 2004. Liposomal amikacin dry powder inhaler: Effect of fines on in vitro performance. AAPS PharmSciTech 5:1–7.
  • LG Sweeney, Z Wang, R Loebenberg, JP Wong, CF Lange, and WH Finlay. 2005. Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery. Int J Pharm 305:180–185.
  • R Vanbever, JD Mintzes, J Wang, J Nice, D Chen, R Batycky, R Langer, and DA Edwards. 1999. Formulation and physical characterization of large porous particles for inhalation. Pharm Res 16:1735–1742.
  • DJ van Drooge, WL Hinrichs, BH Dickhoff, MN Elli, MR Visser, GS Zijlstra, and HW Frijlink. 2005. Spray freeze drying to produce a stable delta(9)-tetrahydrocannabinol containing inulin-based solid dispersion powder suitable for inhalation. Eur J Pharm Sci 26:231–240.
  • FM Wigley, JH Londono, and JH Wood. 1971. Insulin across respiratory mucosa by aerosol delivery. Diabetes 20:552–556.
  • H Yamamoto, Y Kuno, S Sugimoto, H Takeuchi, and Y Kawashima. 2005. Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions. J Control Release 102:373–381.
  • X Zhang, Q Zhang, and XR Qi. 2001. Structure characteristics of insulin liposomes. Acta Pharm Sin 36:448–451.
  • N Zhang, QN Ping, GH Huang, and WF Xu. 2005. Investigation of lectin-modified insulin liposomes as carriers for oral administration. Int J Pharm 294:247–259.
  • XM Zeng, GP Martin, and C Marriott. 1995. The controlled delivery of drugs to the lung. Int J Pharm 124:149–164.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.